CORRECTING and REPLACING GRAPHIC: Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Shown in a Recent Study to Have Beneficial Effects on Human Health and Well-being
Please replace the graphic with the accompanying corrected graphic on
the release issued May 27, 2019 at 9am BST.
The release reads:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190527005028/en/
Seoul Semiconductor's SunLike Series Natural Spectrum LEDs (Graphic: Business Wire)
SEOUL SEMICONDUCTOR’S SUNLIKE SERIES NATURAL SPECTRUM LEDS SHOWN IN A RECENT STUDY TO HAVE BENEFICIAL EFFECTS ON HUMAN HEALTH AND WELL-BEING
Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced the results of a recent study conducted by Dr. Octavio L. Perez, adjunct researcher in Integrative Lighting at Mount Sinai Hospital in NYC, NY, USA on the non-visual melanopic stimulus of LED sources. The study showed that the company’s SunLike Series natural spectrum LEDs provide up to 21% more melanopic stimulus than conventional LEDs at 4000K, and the same melanopic stimulus as daylight at 6500K (D65).
In addition to the visual effects of light and lighting on people, such as visual acuity and color fidelity, there are also non-visual effects. These non-visual effects can affect human health and well-being in aspects related to sleep, awakeness, alertness, circadian rhythmicity, circadian disruption, performance, and mood. Recent building standards, such as the ‘WELL Building Standard,’ assess these non-visual effects of lighting in buildings in terms of the ‘melanopic stimulus,’ not just in terms of conventional photometry and colorimetry.
The recent study evaluated the M-EDI (CIE DIS S026/E:2018 Melanopic Equivalent Daylight Illuminance) of different light sources at different correlated color temperatures (CCT in K). M-EDI is the only metric compliant with the International System of Units (IS) to evaluate the non-visual stimulus of light and lighting, based on the CIE (the International Commission on Illumination) D65 standard daylight illuminant. The preliminary results indicate that the SunLike Series natural spectrum LEDs provide more melanopic stimulus, at any given CCT, than any other LED light source at the same photopic illuminance (in lux) – up to 21% more M-EDI stimulus compared to a conventional 4000K CRI80 LED (4000K being the prevalent CCT in office and school environments).
A typical 4000K CRI80 LED provides 59.30 M-EDI lux for every 100 photopic lux, and a 4000K SunLike LED provides 71.94 M-EDI lux at the same photopic illuminance level. At 6500K, the SunLike LED delivers 99.95% of the M-EDI melanopic stimulus provided by the CIE D65 daylight standard illuminant at the same photopic illuminance. It means that at 6500K, the SunLike Series LEDs provide the same natural melanopic stimulus as daylight (D65).
The reason for this is that the SunLike Series natural spectrum LEDs have a continuous spectral power distribution (SPD) emission that mimics sunlight spectrum at different CCT, in the visual region not including UV and IR. Conventional LED light sources have a peak at 450nm, followed by a valley at the peak of the melanopic efficiency curve, around 480nm. This peak at 450nm for conventional LEDs may also produce non-desired effects on eye health. The melanopic stimulus of the 6500K SunLike LEDs match the shape of the melanopic stimulus provided by D65, avoiding potential blue light peak and ethical issues.
Human centric lighting solutions go beyond the prevalent visual metrics of photometry colorimetry and conventional lighting design. The SunLike Series natural spectrum LEDs offer better visual appearance and color fidelity (CRI95+), and are specifically designed and engineered to provide more benefits and energy for human health and well-being than any other LED in the marketplace. SunLike Series LEDs are the light source of choice for integrative lighting solutions.
Seoul Semiconductor’s SunLike Series natural spectrum LEDs are the world’s first LEDs to produce light that closely matches the spectrum of natural sunlight. It has also achieved the highest level of eye safety certification from the International Commission on Illumination as an RG-1 level light source with no photo-biological risks.
SunLike Series natural spectrum LEDs were co-developed through the combination of Seoul Semiconductor’s optical semiconductor technology and Toshiba Materials’ TRI-R technology, which defines its original concept as “the light closest to the sun for human well-being.” TRI-R technology enables the spectrum of natural sunlight to be reproduced by a white LED light source. TRI-R is a registered trademark of Toshiba Material Co., Ltd.
The left figure is how the melanopic stimulus of commercial LEDs increases and the right figure shows the same results by family of LEDs. SunLike LEDs provide more melanopic stimulus than the other LEDs (study under publication).
# # #
About Dr. Octavio L. Perez
Dr. Octavio L. Perez is a
passionate professional and scholar who contributes to exploring,
developing and bringing to the real world the benefits of light and
lighting for human wellbeing and wellness, and ultimately health,
integrating in this vision the traditional visual and aesthetical
principles of lighting, altogether with energy savings and
sustainability values. He works internationally as an independent
consultant, focused in human centric lighting (HCL), more precisely
“affective lighting”. He is also an adjunct researcher at Mount Sinai
Hospital in NYC, where he completed his doctoral research with funding
from NIH (National Institutes of Health).
About Seoul Semiconductor
Seoul Semiconductor develops and
commercializes LEDs for automotive, general illumination, specialty
lighting, and backlighting markets. As the second-largest LED
manufacturer globally excluding the captive market, Seoul Semiconductor
holds more than 14,000 patents, offers a wide range of technologies, and
mass produces innovative LED products such as SunLike – delivering the
world’s best light quality in a next-generation LED enabling
human-centric lighting optimized for circadian rhythms; WICOP – a
simpler structured package-free LED which provides market leading color
uniformity and cost savings at the fixture level, providing high lumen
density and design flexibility; NanoDriver Series – the world’s smallest
24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED
technology developed in 2005, including all AC LED-related technologies
from chip to module and circuit fabrication, and nPola, a new LED
product based on GaN-substrate technology that achieves more than ten
times the output of conventional LEDs. UCD constitutes a high color
gamut display which delivers more than 90% NTSC. For more information,
please visit www.seoulsemicon.com/en.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190527005028/en/
Contact information
Seoul Semiconductor Inc.
Jeonghee Kim
Tel:
+82-70-4391-8311
Email: jeonghee.kim@seoulsemicon.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 202525.4.2025 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from April 25–30. “At AACR we will be presenting data from early-stage programs across our oncology portfolio, including for patients with myeloproliferative neoplasms, ovarian cancer and other solid tumors,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These data will guide our approach as we advance our pipeline and seek to transform the treatment landscape for patients with cancer and myeloproliferative neoplasms.” Abstracts accepted for presentation at AACR include: Mini Symposium INCB177054 INCB177054: A Novel, Potent, Orally Bioavailable DGKα/ζ Dual Inhibitor Enhances T-Cell Function and Demonstrates Potent Antitumor Activity (Session Title: Novel Antitumor Agents. April 28, 4:50 p.m. – 5:05 p.m. ET (3:50 p.m. – 4:05 p.m. CT). Abstract #
SLB Announces First-Quarter 2025 Results; Remains Committed to Return a Minimum of $4 Billion to Shareholders in 202525.4.2025 13:50:00 EEST | Press release
SLB (NYSE: SLB) today announced results for the first-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423635499/en/ The exterior of the SLB headquarters in Houston, Texas. First-Quarter Results (Stated in millions, except per share amounts) Three Months EndedChange Mar. 31, 2025 Dec. 31, 2024 Mar. 31, 2024 Sequential Year-on-year Revenue $8,490 $9,284 $8,707 -9% -3% Income before taxes - GAAP basis $1,063 $1,387 $1,357 -23% -22% Income before taxes margin - GAAP basis 12.5% 14.9% 15.6% -241 bps -306 bps Net income attributable to SLB - GAAP basis $797 $1,095 $1,068 -27% -25% Diluted EPS - GAAP basis $0.58 $0.77 $0.74 -25% -22% Adjusted EBITDA* $2,020 $2,382 $2,057 -15% -2% Adjusted EBITDA margin* 23.8% 25.7% 23.6% -186 bps 18 bps Pretax segment operating income* $1,556 $1,918 $1,649 -19% -6% Pretax segment operating margin* 18.3% 20.7% 18.9% -232 bps -60 bps Net income attributable to SLB, excluding charges &
Corona, The World’s Most Valuable Beer Brand 1 , Announces Its 100-Year Anniversary with Global Celebration25.4.2025 11:00:00 EEST | Press release
Today, Corona proudly celebrates its 100-year anniversary, a remarkable milestone for the iconic brand that has been synonymous with the beach and enjoyed by consumers worldwide for the past century. Since 1925, Corona has cultivated a deep association with the beach; fully embodying a lifestyle connected to nature and relaxation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425804516/en/ Corona 100 This Is Living Since 1925 In honor of the occasion, Corona invites everyone to live their “beach side” – a.k.a. their best side – at top-tier beach locations across the globe. The Corona 100 platform includes a film highlighting 100 years of beach culture, a definitive list of the top 100 beaches in the world to visit, and a signed multi-year sponsorship of a renowned concert at Copacabana Beach in Rio de Janeiro — all offering people across the globe opportunities to connect with their beach side. “For 100 years, Corona has
Ant Group Unveils New Recruitment Initiative for Top AI Talents, Ramping Up AI Innovation Efforts25.4.2025 10:28:00 EEST | Press release
Ant Group today unveiled Plan A, a new recruitment initiative to attract top artificial intelligence researchers, reinforcing its commitment to accelerating AI research and development under the “AI First” corporate strategy. Operating within the framework of Ant Star—Ant Group’s year-round campus recruitment program—Plan A specifically targets AI talents who are ambitious, adaptable, altruistic, and analytical. Outstanding graduates from universities worldwide with STEM majors are encouraged to apply for Plan A. Relevant fields include computer science, software engineering, artificial intelligence, cybersecurity, information and telecommunication engineering, mathematics, statistics, and other emerging interdisciplinary areas. To better foster the development of technological innovators in this new AI era, Plan A offers candidates comprehensive support and resources, including unrestricted access to AI hardware and tailored career paths that allow for significant research freedom. Ad
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom